跳至主要内容
临床试验/EUCTR2010-020452-64-GB
EUCTR2010-020452-64-GB进行中(未招募)1 期

A prospective randomisd open label study to determine the effects of intravenous iron administration on markers of acute kidney injury in chronic kidney disease (CKD) - Effects of intravenous iron therapy on markers of acute kidney injury

Hull and East Yorkshire Hospitals NHS Trust0 个研究点目标入组 100 人开始时间: 2010年10月8日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients with established chronic kidney disease. (Stages III-V) (GFR using MDRD <60ml/min) who are to undergo iron therapy
  • Male, female over 18 years
  • Written and signed informed patient consent
  • No previous iron administration in the last 6 weeks
  • Serum ferritin levels less than 200 mcg/l and/or transferrin saturation <20%
  • Able to meet all study requrements
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 0
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • Age < 18 years
  • Ferritin greater than 200 mcg/l and Transferrin saturation >40%
  • Known allergy to iron therapy
  • Haemochromatosis
  • Parenteral iron therapy within the previous 6 weeks
  • Inability to co-operate with study protocol
  • Patients with potential confounding factors to NGAL measurement
  • Patients who do not have renal failure (CKD stage I and II)
  • Patients who are unable or do not wish to give consent.
  • Patients being investigated for potential blood loss
  • Patients with a haematological malignancy/ haemolysis
  • Patients with known haemaglobinopathy
  • Patients with a diagnosis of myeloma
  • current smokers
  • Any other contraindications to Monofer, Venofer or Cosmofer therapy listed on SPC

研究者

发起方
Hull and East Yorkshire Hospitals NHS Trust

相似试验

Iron treatment in patients with known kidney disease | 临床试验